Saxony Capital Management »

Brainstorm Cell Therapeutics shares owned by Saxony Capital Management

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics shares owned by Saxony Capital Management from 13F filings

Historical chart of Saxony Capital Management investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Saxony Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Saxony Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.0k 13k 0.23
2024-06-30 $4.4k 13k 0.34
2024-03-31 $12k 21k 0.56
2023-12-31 $5.8k 21k 0.27

More positions owned by Saxony Capital Management

Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Acwi Etf (ACWI)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Dimensional Etf Trust Inflation Prote (DFIP)
Capital Grp Fixed Incm Etf T Short Duration (CGSD)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Ishares Tr S&p Mc 400gr Etf (IJK)
Ishares Tr Jpmorgan Usd Emg (EMB)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Ishares Tr S&p 500 Grwt Etf (IVW)
Eli Lilly & Co. (LLY)

View all positions for Saxony Capital Management

Top funds holding Brainstorm Cell Therapeutics

Geode Capital Management
BlackRock
Liberty Wealth Management
Weaver Consulting Group
Susquehanna International
Northern Trust
Raymond James & Associates
Jmac Enterprises
Wells Fargo & Company
Group One Trading
Tru Independence Asset Management 2
Citadel Advisors
Janney Montgomery Scott
Creative Planning
Saxony Capital Management

View all funds holding Brainstorm Cell Therapeutics